Resultados globales: 3 registros encontrados en 0.02 segundos.
Artículos, Encontrados 3 registros
Artículos Encontrados 3 registros  
1.
17 p, 921.2 KB Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes / Sauta, Elisabetta (Humanitas Clinical and Research Center (Itàlia)) ; Robin, Marie (Department of Hematology and Bone Marrow Transplantation. Hôpital Saint-Louis (França)) ; Bersanelli, Mateo (Department of Biomedical Sciences. Humanitas University) ; Travaglino, Erica (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Meggendorfer, Manje (Mll Munich Leukemia Laboratory) ; Zhao, Lin-Pierre (Department of Hematology and Bone Marrow Transplantation. Hôpital Saint-Louis (França)) ; Caballero Berrocal, Juan Carlos (Hematology Department. Hospital Universitario de Salamanca) ; Sala, Claudia (Experimental. Diagnostic and Specialty Medicine. Dimes) ; Maggioni, Giulia (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Bernardi, Massimo (University Vita-Salute San Raffaele (Itàlia)) ; Di Grazia, Carmen (Irccs Ospedale Policlinico San Martino) ; Vago, Luca (University Vita-Salute San Raffaele (Itàlia)) ; Rivoli, Giulia (Irccs Ospedale Policlinico San Martino) ; Borin, Lorenza (Ospedale San Gerardo) ; D'Amico, Saverio (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Tentori, Cristina Astrid (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Ubezio, Marta (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Campagna, Alessia (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Russo, Antonio (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Mannina, Daniele (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Lanino, Luca (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Chiusolo, Patrizia (Università Cattolica Del Sacro Cuore) ; Giaccone, Luisa (Department of Molecular Biotechnology and Health Sciences. University of Turin) ; Voso, Maria Teresa (Tor Vergata University) ; Riva, Maria (Asst Grande Ospedale Metropolitano Niguarda) ; Oliva, Esther Natalie (Grande Ospedale Metropolitano Bianchi Melacrino Morelli) ; Zampini, Matteo (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Riva, Elena (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Nibourel, Olivier (Chu Lille) ; Bicchieri, Marinela (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Bolli, Niccolo (Department of Oncology and Hemato-Oncology. University of Milan) ; Rambaldi, Alessandro (Azienda Ospedaliera Papa Giovanni Xxiii) ; Passamonti, Francesco (Department of Medicine and Surgery. University of Insubria) ; Savevski, Victor (IRCCS Humanitas Clinical and Research Center (Milà, Itàlia)) ; Santoro, Armando (Department of Biomedical Sciences. Humanitas University) ; Germing, Ulrich (Department of Hematology. Heinrich-Heine-University. University Clinic) ; Kordasti, Shahram (Hematology Department. DISCLIMO-Università Politecnica Delle Marche) ; Santini, Valeria (University of Florence) ; Diez-Campelo, María (Hospital Universitario de Salamanca) ; Sanz, Guillermo (Hospital Universitari i Politècnic La Fe (València)) ; Sole, F (Institut de Recerca Contra la Leucèmia Josep Carreras) ; Kern, Wolfgang (Mll Munich Leukemia Laboratory) ; Platzbecker, Uwe (University Hospital Leipzig) ; Arenillas, Leonor (Department of Hematology and Bone Marrow Transplantation. Hôpital Saint-Louis) ; Fenaux, Pierre (Department of Hematology and Bone Marrow Transplantation. Hôpital Saint-Louis) ; Haferlach, Torsten (Mll Munich Leukemia Laboratory) ; Castellani, Gastone (Experimental. Diagnostic and Specialty Medicine. Dimes) ; Della Porta, Matteo Giovanni (Department of Biomedical Sciences. Humanitas University)
PURPOSEMyelodysplastic syndromes (MDS) are heterogeneous myeloid neoplasms in which a risk-adapted treatment strategy is needed. Recently, a new clinical-molecular prognostic model, the Molecular International Prognostic Scoring System (IPSS-M) was proposed to improve the prediction of clinical outcome of the currently available tool (Revised International Prognostic Scoring System [IPSS-R]). [...]
2023 - 10.1200/JCO.22.01784
Journal of Clinical Oncology, Vol. 41 Núm. 15 (20 2023) , p. 2827-2842  
2.
20 p, 525.5 KB Managing hematological cancer patients during the COVID-19 pandemic : an ESMO-EHA Interdisciplinary Expert Consensus / Buske, Christian (University Hospital of Ulm (Alemanya)) ; Dreyling, M. (Department of Medicine III at LMU Hospital) ; Álvarez Larrán, Alberto (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Apperley, Jane (Imperial College London) ; Arcaini, Luca (University of Pavia) ; Besson, Caroline (UVSQ. Inserm. CESP) ; Bullinger, Lars (Charité - Universitätsmedizin Berlin) ; Corradini, Paolo (University of Milan) ; Della Porta, Matteo Giovanni (Humanitas University) ; Dimopoulos, Meletios (National and Kapodistrian University of Athens) ; D'Sa, Shirley (University College London Hospitals NHS Foundation Trust) ; Eich, H.T. (University of Muenster) ; Foà, R. (Sapienza University) ; Ghia, P. (Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele) ; da Silva, M.G. (Portuguese Institute of Oncology) ; Gribben, J. (Queen Mary University of London) ; Hajek, Roman (University of Ostrava) ; Harrison, C. (Guy's and St Thomas' NHS Foundation Trust) ; Heuser, M. (Hannover Medical School) ; Kiesewetter, Barbara (Medical University of Vienna) ; Kiladjian, Jean-Jacques (Université de Paris) ; Kroeger, Nicolaus (University Hospital Hamburg-Eppendorf) ; Moreau, Philippe (University Hospital Hotel-Dieu) ; Passweg, Jakob R. (University Hospital Basel (Basilea, Suïssa)) ; Peyvandi, Flora (University of Milan) ; Rea, Delphine (Hôpital Saint-Louis) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Robak, Tadeusz (Medical University of Lodz) ; San-Miguel, J (Clínica Universidad de Navarra) ; Santini, Valeria (University of Florence) ; Sanz, G. (CIBERONC. IS Carlos III) ; Sonneveld, P. (Erasmus MC Cancer Institute) ; Von Lilienfeld-Toal, M. (Hans Knöll Institute) ; Wendtner, Clemens-Martin (Ludwig-Maximilian University) ; Pentheroudakis, G. (European Society for Medical Oncology) ; Passamonti, Francesco (University of Insubria)
Background: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group. [...]
2022 - 10.1016/j.esmoop.2022.100403
ESMO open, Vol. 7 Núm. 2 (april 2022) , p. 100403  
3.
15 p, 3.4 MB Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS / Kuendgen, A. (University Hospital Duesseldorf) ; Nomdedeu, Meritxell (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Tuechler, H. (Boltzmann Institute for Leukemia Research. Hanusch Hospital) ; Garcia-Manero, Guillermo (MD Anderson Cancer Center) ; Komrokji, R. S. (H Lee Moffitt Cancer Center) ; Sekeres, M. A. (Taussig Cancer Institute. Cleveland Clinic) ; Della Porta, M. G. (Humanitas Research Hospital (Itàlia)) ; Cazzola, Mario (IRCCS Policlinico San Matteo Foundation) ; DeZern, A. E. (Johns Hopkins University. Sidney Kimmel Comprehensive Cancer Center) ; Roboz, G. J. (Weill Cornell Medicine and The New York Presbyterian Hospital) ; Steensma, D. P. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Van de Loosdrecht, A. A. (Vrije Universiteit Amsterdam) ; Schlenk, R. F. (Heidelberg University Hospital (Alemanya)) ; Grau, J. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Calvo, Xavier (Institut Hospital del Mar d'Investigacions Mèdiques) ; Blum, S. (Lausanne University Hospital) ; Pereira, A. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Valent, P. (Medical University of Vienna) ; Costa, D. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Giagounidis, A. (Marienhospital Duesseldorf) ; Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Döhner, H. (University Hospital of Ulm (Alemanya)) ; Platzbecker, Uwe (University Hospital Leipzig) ; Pedro, Carme (Hospital del Mar (Barcelona, Catalunya)) ; Lübbert, M. (University Medical Center Freiburg) ; Oiartzabal, I. (Arabako Unibertsitate Ospitalea (Vitoria, País Basc)) ; Díez-Campelo, M. (Hospital Universitario de Salamanca) ; Cedena, María Teresa (Hospital Universitario 12 de Octubre (Madrid)) ; Machherndl-Spandl, S. (St Vincent's Hospital (Sydney)) ; López-Pavía, M. (Hospital General Universitario de Valencia) ; Baldus, C. D. (Universitätsklinikum Schleswig-Holstein (Alemanya)) ; Martinez-de-Sola, M. (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Stauder, R. (Innsbruck Medical University) ; Merchan, B. (Hospital Universitari Vall d'Hebron) ; List, A. (H Lee Moffitt Cancer Center) ; Ganster, Christina (University Medical Center Göttingen) ; Schroeder, T. (University Hospital Duesseldorf) ; Voso, Maria Teresa (Tor Vergata University. Department of Biomedicine and Prevention) ; Pfeilstöcker, M. (Hanusch Krankenhaus Wien) ; Sill, H. (Medizinische Universität Graz) ; Hildebrandt, B. (University Duesseldorf. Institute of Human Genetics) ; Esteve Reyner, Jordi (Hospital Clínic i Provincial de Barcelona) ; Nomdedeu, B. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Cobo, Fernando (Hospital Quirón Teknon) ; Haas, R. (University Hospital Duesseldorf) ; Sole, F. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Germing, U. (University Hospital Duesseldorf) ; Greenberg, P. L. (Stanford University Cancer Center) ; Haase, Detlef (University Medical Center Göttingen) ; Sanz, Guillermo (Hospital Universitari i Politècnic La Fe (València)) ; Universitat Autònoma de Barcelona
In the current World Health Organization (WHO)-classification, therapy-related myelodysplastic syndromes (t-MDS) are categorized together with therapy-related acute myeloid leukemia (AML) and t-myelodysplastic/myeloproliferative neoplasms into one subgroup independent of morphologic or prognostic features. [...]
2020 - 10.1038/s41375-020-0917-7
Leukemia, 2020  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.